子宫内膜癌手术后一年内下肢淋巴水肿及淋巴囊肿发生率:一项前瞻性纵向多中心研究
瑞典14家医院前瞻性纵向多中心研究纳入235例子宫内膜癌女性,116例接受淋巴结清扫(+LA)、119例未清扫(-LA),术后一年按腿围体积法、临床分级法和患者报告法评估下肢淋巴水肿(LLL)发生率,并行阴道超声评估淋巴囊肿。+LA组体积法LLL为15.8%、-LA组为3.4%;临床分级分别为24.1%和11.8%;患者报告分别为10.7%和5.1%;术后一年淋巴囊肿发生率为4.3%。作者认为不同测量方法所得发生率差异明显,强调临床与研究需建立LLL测量的「金标准」。
要点
- 术后一年+LA组体积法LLL发生率15.8%,-LA组3.4%。
- 临床分级法LLL发生率+LA组24.1%、-LA组11.8%。
- 患者报告LLL发生率+LA组10.7%、-LA组5.1%。
核心结论
- 子宫内膜癌手术含淋巴结清扫后一年内LLL与淋巴囊肿发生率似乎相对较高,且发生率随测量方法不同而存在显著差异,作者强调临床实践与研究中需建立LLL测量的「金标准」。
研究设计与样本
- 前瞻性纵向多中心研究,在瑞典14家医院开展。
- 共纳入235例子宫内膜癌女性,其中116例手术包含淋巴结清扫(+LA),119例未行淋巴结清扫(-LA)。
- LLL在术前、术后4-6周、6个月及1年共4个时点评估,包括系统测量腿围计算腿体积、LLL临床分级,以及采用淋巴水肿特异性生活质量工具评估患者自我感知的淋巴水肿。
- 淋巴囊肿通过阴道超声评估。
主要发现
- 术后一年,经体质指数校正的腿体积增加所定义的LLL发生率在+LA组为15.8%,在-LA组为3.4%。
- 临床分级对应的LLL发生率在+LA组为24.1%,在-LA组为11.8%。
- 患者报告感知的LLL发生率在+LA组为10.7%,在-LA组为5.1%。
- 患者报告LLL与临床分级之间一致性为fair至moderate相关,而体积增加与患者报告LLL或临床分级之间一致性差。
- 术后一年淋巴囊肿发生率为4.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study aimed to determine the incidence of lower limb lymphedema (LLL) after surgery for endometrial cancer (EC) by means of three methods, and to determine the incidence of lymphocysts after one year. METHODS: A prospective longitudinal multicenter study was conducted in 14 hospitals in Sweden. Two-hundred-and-thirty-five women with EC were included; 116 underwent surgery that included lymphadenectomy (+LA) and 119 were without lymphadenectomy (-LA). Lymphedema was assessed objectively on four occasions; preoperatively, at 4-6 weeks, six months and one year postoperatively using systematic measurement of leg circumferences, enabling calculation of leg volumes, and a clinical grading of LLL, and subjectively by the patient's perception of lymphedema measured by a lymphedema-specific quality-of-life instrument. Lymphocyst was evaluated by vaginal ultrasonography. RESULTS: After one year the incidence of LLL after increase in leg volume adjusted for body mass index was 15.8% in +LA women and 3.4% in -LA women. The corresponding figures for clinical grading were 24.1% and 11.8%, and for patient-reported perceived LLL 10.7% and 5.1%. The agreement between the modalities revealed fair to moderate correlation between patient-reported LLL and clinical grading, but poor agreement between volume increase and patient-reported LLL or clinical grading. Lymphocysts were found in 4.3% after one year. CONCLUSIONS: Although the incidence of LLL and lymphocysts after surgery for EC including LA seemed to be relatively high the study demonstrated significant variations in incidence depending on the measurement modality. This emphasizes the need for a 'gold standard' of measurement of LLL in clinical practice and research.
引用
- Wedin M, Stålberg K, Marcickiewicz J, et al. Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study. Gynecol Oncol. 2020. PMID: 32763108. doi:10.1016/j.ygyno.2020.07.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。